The abstract is read at the publisher; the summary is JClub's.
In a hamster model of SARS-CoV-2 infection, combining Poly IC and FK506 suppresses viral load and lung injury across Beta, Delta, and EG.1 variants, reducing mortality and severe illness.
- Why it matters: Respiratory viruses mutate rapidly, weakening virus-target vaccines and antibodies and creating a need for host-target immunotherapies that remain effective across variants.
- What they did: The study mapped variant-specific lung transcriptomes in hamsters and tested a pharmacological combination that activates innate immunity with Poly IC and inhibits adaptive immunity with FK506.
- The result: The Poly IC–FK506 synergism significantly reduced mortality and severe illness, and the approach also worked in humanized mice infected with SARS-CoV-2, H1N1, and H3N2, implying broad cross-virus potential.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.